High throughput liquid chromatography mass spectrometry (LC-MS) based proteomic analysis has emerged as a powerful tool for functional annotation of genome sequences. These analyses complement the bioinformatic and experimental tools used for deriving, verifying and functionally annotating models of genes and their transcripts. Furthermore, proteomics extends verification and functional annotation to the level of the translation product of the gene model.
Introduction
The explosion of genome sequencing projects in the last decade has been an enormous boon to biological researchers. However, the quantity of DNA sequence data presents a challenge for annotation and use. The development and refinement of algorithms for annotation of genome sequences has been crucial for providing in silico predicted gene models. This is especially true for eukaryotic genomes with the additional complexity of introns and exons.
Expressed sequence tag (EST) data are critical for experimental verification of predicted transcripts from the gene models. The placement of splice sites, information about transcription start sites and untranslated regions of the gene can be derived from the EST data.
Analogous to the use of EST data, the use of high throughput LC-MS based proteomic data to experimentally verify and adjust predicted models for translation products of the gene models has begun to emerge. An organism can be grown under diverse sets of conditions and the extracted proteins pooled before analysis in order to maximize the proportion of the proteome that is observed. Alternatively, specific growth conditions at specific developmental stages or time points can be analyzed separately to extend the functional annotation of a proportion of the proteome, e.g., associate a subset of proteins with a particular metabolic state. Similar to EST data, proteomics data can be used to verify splice sites in transcripts where the identified peptides span an exon/intron/exon boundary. But proteomics data adds an additional dimension of functional annotation, as it can be used to verify predicted translation start and stop sites, signal peptide cleavage sites and post-translational protein modifications.
Materials

NCBI BLAST:
The programs needed for BLAST based mapping of peptides are available for a variety of operating systems for free download from the NCBI (www.ncbi.nlm.nih.gov/BLAST/download.shtml; Altschul et al 1997).
Genome sequence:
A complete or high coverage draft genome sequence.
Gene models:
Gene models are generated for a given genome by automated gene calling software, such as Genewise (Birney & Durbin, 2000) or Fgenesh (Salamov & Solovyev, 2000) .
Peptide sequence data from global proteomic experiment(s):
Must be in a format, such as FASTA, that is compatible with command-line batch BLAST analysis.
Methods
Proteomic analysis.
Global proteomic analysis is used to determine the sequences of peptides present in a protein sample.
Peptide mapping.
Peptides that have been identified in the previous step are mapped to the genome sequence using the tblastn tool with the following options:
tblastn -e 1000 -W 2 -F F -f 6 -K 50
The expectation value (-e option) is given the large value of 1000 in order to collect short matches to the genome. A very short word size of 2 (-W option) is used to increase the sensitivity of the blast algorithm. Turning off the filtering (-F option) is also essential for successfully matching short peptides to the genome. A lower threshold value is used to extend the length of the matches (-f option). Because the lower thresholds generate a lot of matches, and only one or two are true matches the number of alignments reported is lowered to 50 (-K option).
Quality assessment.
After the peptides are mapped to the genome, a best match is selected for each peptide. The quality of the peptide matches are assessed with respect to percent sequence identity and percent coverage. The peptide is further categorized based on the presence or absence of a gap. Based on the collective criteria the peptides are assigned to one of the following categories:
Perfect match:
100% sequence identity without gaps in the alignment covering more than 98% of the peptide sequence.
Split match: two non-overlapping fragments of a peptide exhibit perfect matches to two genomic sequences in close proximity.
Total coverage is equal to 100% of the peptide.
Imperfect match: 80-99% sequence identity, 90-98% coverage. (Fig. 2) . The difference between the number of locations and the number of total peptides reflects the existence of non-unique peptide matches and split matches.
A total of 224 split matches were detected with 107 perfect and 117 imperfect split matches providing support for splice boundaries in genes containing two or more exons. Excluding the uncertain peptides, support was provided for 2,795 exons representing 1,440 of 10,048 predicted gene models.
Database searching.
There are a number of different algorithms available for searching mass spectrometry generated peptide data against protein databases. In the example in Note 4. Xcorr is a statistical estimate of the cross-correlation sequence of a random process. In this application, it is a measure of the quality of the match of the peptide derived from the mass spectral data to the peptide determined from translation of the genome sequence. In general, the most important aspect of accurate peptide identification is the use of stringent parameters, regardless of the algorithm.
Peptide format.
Peptide sequences should be in FASTA format.
Data display.
The procedure is designed for work with the JGI Genome Portal (Figure 3; genome.jgi-psf.org) and the underlying mySQL database. However, this procedure can easily be modified for any genome browser that displays "features", such as gene models, on "tracks" 
